Cancer diagnostics company Pacific Edge has raised $16 million from existing shareholders after a placement of new shares, $1m more than expected, after accepting over subscriptions.
The placement was completed on Friday and is subject to shareholder approval. It was priced at 10 cents per share, an
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
